PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

CVS PHARMACY, INC.

USPTO PatentsView assignee record — 122 granted patents across 26 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).

Explore the portfolio See the ranking
122
Total patents granted
26
CPC technology areas
11.0
Avg claims per patent
+54%
5-year filing velocity

The verdict

CVS holds 122 US patents across 26 technology areas — rank #3,091 of 50,000 tracked assignees.

#3,091
of 50,000 US assignees by volume
Top 9%
by Innovation Score (53.4/100)
11.0
avg claims per patent
+54%
filing velocity, last 5 yrs

Portfolio overview

CVS PHARMACY, INC. has been granted 122 US utility patents between 2016 and 2025, placing CVS PHARMACY, INC. at rank #3,091 across all assignees tracked by PlainPatent. This portfolio spans 26 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.0 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, CVS PHARMACY, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 74 grants, compared with 48 in the 2015–2019 window — a +54% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. CVS PHARMACY, INC.'s 11.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 26 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark CVS PHARMACY, INC. against peers pursuing similar technology classes.

How does CVS compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows CVS holds 122 patents — placing it at rank #3,091 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

CVS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

010203040 2016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
CVS PHARMACY, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 2.5%
2017 16 13.1%
2018 14 11.5%
2019 15 12.3%
2020 5 4.1%
2021 8 6.6%
2022 7 5.7%
2023 15 12.3%
2024 29 23.8%
2025 10 8.2%

Which technologies does CVS PHARMACY, INC. patent most?

Top 15 of 26 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,091

Across all tracked assignees

Innovation Score

53.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does CVS PHARMACY, INC. hold?
CVS PHARMACY, INC. holds 122 US granted patents filed between 2016 and 2025, spanning 26 technology areas.
What is CVS PHARMACY, INC.'s Innovation Score?
CVS PHARMACY, INC. has an Innovation Score of 53.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does CVS PHARMACY, INC. focus on?
CVS PHARMACY, INC.'s top technology area is G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA) with 34 patents. The company has filed patents in 26 CPC subclasses total.
Is CVS PHARMACY, INC.'s patent filing rate increasing or decreasing?
CVS PHARMACY, INC.'s recent filing velocity is +54% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for CVS PHARMACY, INC.'s patents?
CVS PHARMACY, INC.'s patents average 11.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the CVS PHARMACY, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

G16H technology

CVS PHARMACY, INC.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where CVS PHARMACY, INC. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope